Prescription Drugs

Multiemployer Plan and Public Employer Coverage of GLP-1 Drugs

Cara McMullin
 

New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Is Almost Ten Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer and plan sponsor coverage surrounding glucagon-like peptide-1 […]

Employers Grapple with Claims Costs versus Outcomes of GLP-1 Drugs

Anne Patterson
 

A new survey report from the International Foundation of Employee Benefit Plans reveals U.S. employer coverage and considerations surrounding glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes. These drugs were also found to cause weight loss and have […]